WO2007067672A3 - Procede de prediction de progression systemique chez des patients atteints de cancer de la prostate - Google Patents

Procede de prediction de progression systemique chez des patients atteints de cancer de la prostate Download PDF

Info

Publication number
WO2007067672A3
WO2007067672A3 PCT/US2006/046643 US2006046643W WO2007067672A3 WO 2007067672 A3 WO2007067672 A3 WO 2007067672A3 US 2006046643 W US2006046643 W US 2006046643W WO 2007067672 A3 WO2007067672 A3 WO 2007067672A3
Authority
WO
WIPO (PCT)
Prior art keywords
prostate cancer
cancer patients
systemic progression
predict systemic
predict
Prior art date
Application number
PCT/US2006/046643
Other languages
English (en)
Other versions
WO2007067672A2 (fr
Inventor
Michael Kattan
Kevin M Slawin
Original Assignee
Baylor College Medicine
Sloan Kettering Inst Cancer
Michael Kattan
Kevin M Slawin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine, Sloan Kettering Inst Cancer, Michael Kattan, Kevin M Slawin filed Critical Baylor College Medicine
Publication of WO2007067672A2 publication Critical patent/WO2007067672A2/fr
Publication of WO2007067672A3 publication Critical patent/WO2007067672A3/fr

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06G—ANALOGUE COMPUTERS
    • G06G1/00—Hand manipulated computing devices
    • G06G1/0005—Hand manipulated computing devices characterised by a specific application
    • G06G1/001—Hand manipulated computing devices characterised by a specific application for medical purposes, for biological purposes

Landscapes

  • Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • General Physics & Mathematics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

La présente invention concerne des procédés et un appareil pour la prédiction de la probabilité de l'absence de la progression de métastases chez de patients atteints du cancer de la prostate.
PCT/US2006/046643 2005-12-06 2006-12-06 Procede de prediction de progression systemique chez des patients atteints de cancer de la prostate WO2007067672A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74301805P 2005-12-06 2005-12-06
US60/743,018 2005-12-06

Publications (2)

Publication Number Publication Date
WO2007067672A2 WO2007067672A2 (fr) 2007-06-14
WO2007067672A3 true WO2007067672A3 (fr) 2008-05-08

Family

ID=38016820

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/046643 WO2007067672A2 (fr) 2005-12-06 2006-12-06 Procede de prediction de progression systemique chez des patients atteints de cancer de la prostate

Country Status (1)

Country Link
WO (1) WO2007067672A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
EP2591126B1 (fr) 2010-07-07 2020-12-30 Myriad Genetics, Inc. Signatures génétiques utilisées pour le pronostic du cancer
WO2012030840A2 (fr) 2010-08-30 2012-03-08 Myriad Genetics, Inc. Signatures génétiques pour le diagnostic et le pronostic du cancer
EP4190918A1 (fr) 2012-11-16 2023-06-07 Myriad Genetics, Inc. Signatures géniques pour le pronostic du cancer
CA2947624A1 (fr) 2014-05-13 2015-11-19 Myriad Genetics, Inc. Signatures genetiques utilisees en vue du pronostic d'un cancer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993388A (en) * 1997-07-01 1999-11-30 Kattan; Michael W. Nomograms to aid in the treatment of prostatic cancer
WO2004027432A2 (fr) * 2002-09-18 2004-04-01 Baylor College Of Medicine Methode de pronostic appliquee a des patients atteints d'une maladie prostatique
WO2005055115A2 (fr) * 2003-11-26 2005-06-16 Memorial Sloan-Kettering Cancer Center Procede de prevision d'une biopsie de la prostate a repetition positive
WO2005088313A1 (fr) * 2004-03-11 2005-09-22 Baylor College Of Medicine Procede de prediction du risque de progression de bph
WO2005111625A2 (fr) * 2004-05-11 2005-11-24 Baylor College Of Medicine Methode de prediction du risque de cancer de la prostate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993388A (en) * 1997-07-01 1999-11-30 Kattan; Michael W. Nomograms to aid in the treatment of prostatic cancer
WO2004027432A2 (fr) * 2002-09-18 2004-04-01 Baylor College Of Medicine Methode de pronostic appliquee a des patients atteints d'une maladie prostatique
WO2005055115A2 (fr) * 2003-11-26 2005-06-16 Memorial Sloan-Kettering Cancer Center Procede de prevision d'une biopsie de la prostate a repetition positive
WO2005088313A1 (fr) * 2004-03-11 2005-09-22 Baylor College Of Medicine Procede de prediction du risque de progression de bph
WO2005111625A2 (fr) * 2004-05-11 2005-11-24 Baylor College Of Medicine Methode de prediction du risque de cancer de la prostate

Also Published As

Publication number Publication date
WO2007067672A2 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
EP2000543A4 (fr) Procédé destiné au diagnostic moléculaire du cancer de la prostate et nécessaire destiné à mettre en oeuvre ce procédé
WO2006015263A3 (fr) Analogues de lonidamine
HK1108284A1 (en) Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
EP2061899A4 (fr) Biomarqueurs du cancer de la prostate et procédés les utilisant
WO2008058021A3 (fr) Méthodes pour traiter des maladies néoplasiques, auto-immunes, et inflammatoires
MY148635A (en) Anti-tat226 antibodies and immunoconjugates
MX2009003938A (es) Anticuerpos e inmunoconjugados y sus usos.
GB2441666B (en) Doped semiconductor nanocrystals and methods of making same
GB0508101D0 (en) Methods and apparatus for the manufacture of microstructures
WO2007127010A3 (fr) Composés de diarylthiohydantoïne
GB0620669D0 (en) Methods and apparatus for the extraction of energy from moving water
HK1116249A1 (en) B7-h1 and methods of diagnosis, prognosis, and treatment of cancer b7-h1
HK1077583A1 (en) Cudr as biomarker for cancer progression and therapeutic response
WO2005111625A3 (fr) Methode de prediction du risque de cancer de la prostate
EP1755394A4 (fr) Methode de traitement du cancer
AU2005316238B2 (en) Cancer treatment method
IL179323A0 (en) Cancer treatment method
WO2007067672A3 (fr) Procede de prediction de progression systemique chez des patients atteints de cancer de la prostate
GB0417740D0 (en) Methods and kit for the prognosis of breast cancer
WO2006015191A3 (fr) Analogues de lonidamine multicycliques
IL179359A0 (en) Cancer treatment method
ZA200703482B (en) B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
EP1783231A4 (fr) Procede de degre de decision de la malignite d'un cellule de carcinome
IL186935A0 (en) Prostate cancer field effect analysis methods and kits
GB2470131B (en) Doped semiconductor nanocrystals and methods of making same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06844933

Country of ref document: EP

Kind code of ref document: A2